EXPERIMENTAL AND THEORETICAL APPROACHES TO STRUCTURAL, SPECTROSCOPIC, ELECTRONIC, AND NLO PROPERTIES INSECTICIDE CHLORANTRANILIPROLE: MOLECULAR DOCKING AND ADMET ANALYSIS
BULLETIN OF THE CHEMICAL SOCIETY OF ETHIOPIA, cilt.40, sa.4, ss.735-754, 2026 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 40 Sayı: 4
- Basım Tarihi: 2026
- Doi Numarası: 10.4314/bcse.v40i4.2
- Dergi Adı: BULLETIN OF THE CHEMICAL SOCIETY OF ETHIOPIA
- Derginin Tarandığı İndeksler: Scopus, Science Citation Index Expanded (SCI-EXPANDED), Directory of Open Access Journals
- Sayfa Sayıları: ss.735-754
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Süleyman Demirel Üniversitesi Adresli: Evet
Özet
This study aims to investigate the molecular geometry, biological activities, and electronic and
vibrational properties of 5-bromo-N-[4-chloro-2-methyl-6-(methylcarbamoyl)phenyl]-2-(3-chloropyridin-2-
yl)pyrazole-3-carboxamide(Chlorantraniliprole). To support the theoretical results, experimental measurements of
FTIR, Raman, and UV-Vis spectra were performed. Using the DFT/B3LYP/6–311 G(d,p) basis set, the ground
state geometry and electronic structure of chlorantraniliprole were optimized. To predict the chemical reactivity of
the chlorantraniliprole molecule, molecular electrostatic potential (MEP) maps, frontier molecular orbital (FMO)
analysis, and electronic reactivity descriptors were employed. The energies of the highest occupied molecular orbital
(HOMO) and lowest unoccupied molecular orbital (LUMO) were examined to elucidate the intramolecular charge
transfer characteristics. Natural bond orbital (NBO) analysis was conducted to evaluate the electronic characteristics
and stabilization energies of intra- and intermolecular hydrogen bonding interactions. Molecular docking studies
were performed with human DNA (1BNA) and tumor suppressor protein p53 (2ACO) to explore potential off-target
interactions of chlorantraniliprole. The best binding affinities, based on the results, were determined to be -7.1 and
-6.7 kcal/mol, respectively. The compound chlorantraniliprole demonstrates an unfavorable pharmacokinetic profile
for human health, based on drug likeness, physicochemical properties, and ADMET data.